About
John Peryam, a J.D. and Founding Partner of Fulcrum Global Capital, has about 20 years of experience structuring, financing, and growing early-stage companies. At FGC he concentrates on automation/robotics, crop inputs, fintech, and novel crops and products across the food production system. He previously served as General Counsel of the Kansas Bioscience Authority, overseeing legal work and early-stage investments, and spent a decade in private legal practice handling M&A, securities/fundraising, and corporate matters.
Invests in
AgTechFintechRobotics
Experience
- Fulcrum Global CapitalManaging Partnercurrent2016 — present
- SabantoBoard Membercurrent2022 — present
- Plastomics, Inc.Board Membercurrent2021 — present
- Resilient BioticsBoard Membercurrent2020 — present
- NanoGuard Technologies Inc.Board Membercurrent2019 — presentGreater St. Louis
- GlacierGridBoard Observercurrent2025 — present
- Talam BiotechBoard Observer2020 — 2024
- CoverCress Inc.Board Member2018 — 2022Greater St. Louis
- Kansas Bioscience AuthorityGeneral Counsel2014 — 2016
- Seigfreid Bingham, PCShareholder/Attorney2012 — 2014
- Lewis, Rice & Fingersh, L.C.Associate2004 — 2012
- Standish Mellon Asset ManagementPCA1999 — 2001
Education
- University of Kansas School of LawJD, Law2001 — 2004
- DePauw UniversityBA, Economics and English Writing1995 — 1999
- Kent Denver1993 — 1995
Skills & more
+9 more
Business FormationReal Estate TransactionsPrivate EquityVenture CapitalSecuritiesBusiness TransactionsMergersLicensingLitigationFrom John's professional profile.
Same school
Also attended University of Kansas School of Law2
Also attended DePauw University23
+ 17 more
Shared employers
Also worked at Sabanto3
Also worked at CoverCress Inc.3
Also worked at Kansas Bioscience Authority2
Also worked at Standish Mellon Asset Management1
Deals · 4
Plastomics, Inc.Board seat
via Fulcrum Global Capital · filed Dec 2021 · $7.1M raise
NanoGuard TechnologiesBoard seat
via Fulcrum Global Capital · filed Nov 2021 · $3.5M raise
Resilient BioticsBoard seat
via Fulcrum Global Capital · filed Dec 2020 · $7.2M raise
ArvegenixBoard seat
via Fulcrum Global Capital · filed Apr 2020 · $5.3M raise
Attribution from SEC filings, press coverage, and firm rosters.














